PCPC3 — the patient-centered prostate cancer collaborative coalition — was initially conceived and discussed by a group of patient education and advocacy organizations attending the annual meeting of the American Urological Association in New Orleans on May 17, 2015.
A second meeting of representatives of founding members of the group was then held in Chicago at the annual meeting of the American Society of Clinical Oncology on May 31, 2015.
PCPC3 is a group of independent, not-for-profit, patient-centric organizations whose primary, shared goals include the education and support of men with diagnosed with prostate cancer, their family members and care-givers, and all men at risk for prostate cancer.
The founding members of PCPC3 are:
- National Alliance of State Prostate Cancer Coalitions (NASPCC)
- Patient Advocates for Advanced Cancer Treatments (PAACT)
- Prostate Cancer International (PCaI)
- Prostate Conditions Education Council (PCEC)
- Prostate Health Education Network (PHEN)
- Us TOO International
The members of PCPC3 are dedicated to
- Ensuring that all adult males and their families understand and are aware of their risk for diagnosis with prostate cancer
- Providing information, education, and support for men who are diagnosed with prostate cancer — and for their care-givers and family members
- Advocating for and educating patients about opportunities for high-quality diagnosis, management, and treatment of prostate cancer and its consequences by primary care and specialist clinicians of all types
- Advocating for advances in the diagnosis and management of prostate cancer over time
- Eliminating prostate cancer as a significant clinical risk factor to the greatest extent possible
and to working together, in collaboration, toward the achievement of this mission.
For additional information please see the PCPC3 web site at www.pcpc3.org.